IF/TA-related metabolic changes - Proteome analysis of rat renal allografts

Nephrology Dialysis Transplantation

Volumn 25, Issue 8, 2010, Pages 2492-2501

  Reuter, Stefan ^a   Reiermann, Stefanie ^a   Wörner, Reka ^a   Schröter, Rita ^a   Edemir, Bayram ^a   Buck, Fritz ^c   Henning, Stefanie ^a   Peter Katalinic, Jasna ^a   Vollenbröker, Beate ^a   Amann, Kerstin ^b   Pavenstädt, Hermann ^a   Schlatter, Eberhard ^a   Gabriëls, Gert ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

IF TA; kidney; metabolism; proteomics

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CREATINE KINASE; ELECTROLYTE; EZRIN; FRUCTOSE 1,6 BISPHOSPHATE; ISOCITRATE DEHYDROGENASE (NADP); ORNITHINE OXOACID AMINOTRANSFERASE; PEROXIREDOXIN 1; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROL GROUP; CONTROLLED STUDY; CYTOSKELETON; DARK AGOUTI RAT; EXPERIMENTAL MODEL; GEL ELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY; IRON RESPONSIVE ELEMENT; KIDNEY FUNCTION; MALE; MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; WISTAR RAT; ALLOTRANSPLANTATION; ANIMAL; ATROPHY; DISEASE MODEL; ENERGY METABOLISM; FIBROSIS; INBRED RAT STRAIN; INTERSTITIAL NEPHRITIS; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEOMICS; WISTAR FURTH RAT;

ANIMALS; ATROPHY; CYTOSKELETON; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FIBROSIS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; NEPHRITIS, INTERSTITIAL; OXIDATIVE STRESS; PROTEOMICS; RATS; RATS, INBRED STRAINS; RATS, INBRED WF; TRANSPLANTATION, HOMOLOGOUS;

EID: 77954783324     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq043     Document Type: Article

References (53)

1. Meier-Kriesche HU, Schold JD, Srinivas TR et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383
2. Pascual M, Theruvath T, Kawai T etal. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med2002; 346: 580-590 (Pubitemid 34438820)
3. Joosten SA, Sijpkens YW, van KC et al. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005; 68: 1-13
4. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
5. Solez K, Colvin RB, Racusen LC et al. Banff'05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526
6. Nankivell BJ, Borrows RJ, Fung CL et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333
7. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313-318
8. Gottmann U, Oltersdorf J, Schaub M et al. Oxidative stress in chronic renal allograft nephropathy in rats: effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol. J Cardiovasc Pharmacol 2003; 42: 442-450
9. Kerjaschki D, Huttary N, Raab I et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006; 12: 230-234
10. Gabriels G, August C, Grisk O et al. Impact of renal transplantation on small vessel reactivity. Transplantation 2003; 75: 689-697
11. Kunter U, Floege J, von Jurgensonn AS et al. Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis. Transplantation 2003; 75: 3-9
12. Savikko J, Taskinen E, Von WE. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: ty- rosine kinase inhibitors as a potential therapy. Transplantation 2003; 75: 1147-1153
13. Reuter S, Velic A, Edemir B et al. Protective role of NHE-3 inhibition in rat renal transplantation undergoing acute rejection. Pflugers Arch 2008;456:1075-1084
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
15. Velic A, Gabriels G, Hirsch JR et al. Acute rejection after rat renal transplantation leads to downregulation of NA+ and water channels in the collecting duct. Am J Transplant 2005; 5: 1276-1285
16. Savikko J, Kallio EA, Taskinen E et al. The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection. Transplantation 2002; 73: 506-511
17. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006; 81: 643-654
18. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfu- sion. J Am Soc Nephrol 2004; 15: 2115-2124
19. Wallimann T, Wyss M, Brdiczka D et al. Intracellular compart- mentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phospho- creatine circuit' for cellular energy homeostasis. Biochem J 1992; 281: 21-40
20. Yanez AJ, Nualart F, Droppelmann C et al. Broad expression of fructose-1,6-bisphosphatase andphosphoenolpyruvate carboxykinase provide evidence for gluconeogenesis in human tissues other than liver and kidney. J Cell Physiol 2003; 197: 189-197
21. Scherer A, Krause A, Walker JR et al. Optimized protocol for linear RNA amplification and application to gene expression profiling of human renal biopsies. Biotechniques 2003; 34: 546-4,556 (Pubitemid 36298179)
22. Pfaller W, Thorwartl U, Nevinny-Stickel M et al. Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injury. Kidney Int Suppl 1994; 47: S68-S75
23. Kotanko P, Keiler R, Knabl L et al. Urinary enzyme analysis in renal allograft transplantation. Clin Chim Acta 1986; 160: 137-144
24. Baicu SC, Simmons PM, Campbell LH et al. Interstitial fluid analysis for assessment of organ function. Clin Transplant 2004; 18: 16-21
25. Marangos PJ, Fox AW, Riedel BJ et al. Potential therapeutic applications of fructose-1,6-diphosphate. Expert Opin Investig Drugs 1998; 7: 615-623
26. Fulladosa X, Moreso F, Narvaez JA et al. Estimation of total glomer- ular number in stable renal transplants. J Am Soc Nephrol 2003; 14: 2662-2668
27. Ishii Y, Sawada T, Kubota K et al. Loss of peritubular capillaries in the development of chronic allograft nephropathy. Transplant Proc 2005; 37: 981-983
28. Di Marco GS, Reuter S, HillebrandU etal. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. J Am Soc Nephrol 2009; 20: 2235-2245
29. Molitoris BA. Putting the actin cytoskeleton into perspective: pathophysiology of ischemic alterations. Am J Physiol 1997; 272: F430-F433
30. White P, Gu L, Chen J. Decreased actin solubility observed during ATP-depletion is mimicked by severing agents but not depolymeriz- ing agents in isolated and cultured proximal tubular cells. Clin Phy- siol Funct Imaging 2002; 22: 312-319
31. Ostalska-Nowicka D, Zachwieja J, Nowicki M et al. Ezrin-a useful factor in the prognosis of nephrotic syndrome in children: an immu- nohistochemical approach. J Clin Pathol 2006; 59: 916-920
32. Levillain O, Hus-Citharel A, Garvi S et al. Ornithine metabolism in male and female rat kidney: mitochondrial expression ofornithine ami- notransferase and arginase II. Am J Physiol Renal Physiol 2004; 286: F727-F738
33. Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005; 5: 641-654
34. Therrien G, Sarhan S, Knodgen B et al. Effects of ornithine amino- transferase inactivation by 5-fluoromethylornithine in rats following portacaval anastomosis. Metab Brain Dis 1994; 9: 211-224
35. Williams NS, Burgett AW, Atkins AS et al. Therapeutic anticancer efficacy of a synthetic diazonamide analog in the absence of overt toxicity. Proc Natl Acad Sci USA 2007; 104: 2074-2079
36. Sullivan DM, Jensen TG, Taichman LB et al. Ornithine-delta-amino- transferase expression and ornithine metabolism in cultured epidermal keratinocytes: toward metabolic sink therapy for gyrate atrophy. Gene Ther 1997; 4: 1036-1044
37. Jones SL, Wang J, Turck CW et al. A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function. Proc Natl Acad Sci USA 1998; 95: 9331-9336
38. Lin CS, Aebersold RH, Kent SB et al. Molecular cloning and characterization of plastin, a human leukocyte protein expressed in transformed human fibroblasts. Mol Cell Biol 1988; 8: 4659-4668
39. Jung K, Kim S, Lee K et al. Cytotoxic effect of a replication-incompetent adenoviral vector with cytosine deaminase gene driven by L- plastin promoter in hepatocellular carcinoma cells. Arch Pharm Res 2007; 30: 770-777
40. Samstag Y, Klemke M. Ectopic expression of L-plastin in human tumor cells: diagnostic and therapeutic implications. Adv Enzyme Regul Adv Enzyme Regul 2007; 47: 118126
41. Djamali A. Oxidative stress as a common pathway to chronic tubu- lointerstitial injury in kidney allografts. Am J Physiol Renal Physiol 2007; 293: F445-F455
42. Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 2005; 7: 768-777
43. Pantopoulos K, Hentze MW. Activation of iron regulatory protein-1 by oxidative stress in vitro. Proc Natl Acad Sci USA 1998; 95: 10559-10563
44. Kil IS, Shin SW, Yeo HS et al. Mitochondrial NADP+-dependent iso- citrate dehydrogenase protects cadmium-induced apoptosis. Mol Pharmacol 2006; 70: 1053-1061
45. Yang L, Luo H, Vinay P et al. Molecular cloning of the cDNA of mouse mitochondrial NADP-dependent isocitrate dehydrogenase and the expression of the gene during lymphocyte activation. J Cell Biochem 1996; 60: 400-410
46. Ogasawara Y, Namai T, Togawa T et al. Formation of albumin dimers induced by exposure to peroxides in human plasma: a possible bio- marker for oxidative stress. Biochem Biophys Res Commun 2006; 340: 353-358
47. Sun Q, Liu ZH, Ji S et al. Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation. Kidney Int 2006; 70: 377-383
48. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820
49. Ellis EM, Slattery CM, Hayes JD. Characterization of the rat aflatoxin B1 aldehyde reductase gene, AKR7A1. Structure and chromosomal localization of AKR7A1 as well as identification of antioxidant response elements in the gene promoter. Carcinogenesis 2003; 24: 727-737
50. Kisucka J, Chauhan AK, Patten IS et al. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ Res 2008; 103: 598-605
51. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997; 18: 533-537
52. Maluf DG, Mas VR, Archer KJ et al. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fi- brosis. Mol Med 2008; 14: 276-285
53. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 2000; 77: S3-S12